1 / 7

Erectile Dysfunction Drugs Market Expected to Growth During the Forecast

Worldwide erectile dysfunction drugs market size is relied upon to enlist a CAGR of 3.5% during the estimated time of 2019 to 2025 with a market worth of USD 2930 million out of 2025. <br><br>

vinitsawant6675
Download Presentation

Erectile Dysfunction Drugs Market Expected to Growth During the Forecast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Erectile Dysfunction Drugs Market Global Industry Survey, Growth, Competitive Landscapeand Forecasts to 2025 CREATED BY Market Research Future (Part of Wantstats Research & Media Pvt. Ltd.)

  2. Erectile Dysfunction Drugs Market Global Research Report - Forecast till 2025 Market Insights: Market Research Future (MRFR) believes that the erectile dysfunction drugs market can record a growth rate of 3.5% between 2019 and 2025. MRFR also conjectures that the market value by 2025 should be USD 2930 million. Major Boosters and Impediments Mental health issues and stress are known for triggering the erectile dysfunction condition. Psychological and physical challenges can also result in erectile dysfunction. Sedentary lifestyle, alcohol consumption and smoking are a few other exacerbating factors. The UK Health Centre reports that close to 50 percent of total men in the country smoke a complete packet of cigarette in a day and are therefore, at a higher risk of developing ED. The erectile dysfunction market is making significant progress backed by the mounting patient awareness as well as education level. Expanding geriatric patient pool, surge in a number of lifestyle diseases and the social stigma associated with ED could also foster further market growth. Brand loyalty coupled with rising acceptance of established brands such as Viagra, Levitra/Staxyn and Cialis will also add to the market value in the ensuing years. www.marketresearchfuture.com

  3. Erectile Dysfunction Drugs Market Global Research Report - Forecast till 2025 Segmentation Analysis The global market for erectile dysfunction drugs has been considered for drug and end-user. The major drugs available in the market for ED are cialis (tadalafil), viagra (sildenafil citrate), stendra/spedra (avanafil), staxyn/levitra (vardenafil), vitaros (alprostadil cream), zydena (udenafil), and more. The highest demand is witnessed by the viagra drug and therefore, the segment is on track to secure the leading position in the market. Viagra has been the first drug to ever achieve the Food and Drug Administration approval for oral consumption to treat erectile dysfunction. The Viagra drug was introduced by Pfizer in 1998 and has been ruling the global market ever since. Cialis drug, on the other hand, has been growing at a swift rate in the global industry, since it provides an erection for a longer period compared to viagra, which is close to 18 hours and above whereas viagra only ensures erection for 4 to 6 hours. Major end users in the global market are retail pharmacy, online pharmacy and hospital pharmacy. Retail pharmacy should be the top segment in the years ahead, because of the high availability of a number of such stores. Hospital pharmacy will emerge as the fastest expanding segment in the near future, owing to the widening patient pool being admitted in hospitals. Get Sample Report: https://www.marketresearchfuture.com/sample_request/1313 www.marketresearchfuture.com

  4. Erectile Dysfunction Drugs Market Global Research Report - Forecast till 2025 Regional Analysis The key markets for erectile dysfunction drugs are the Americas, APAC or Asia Pacific, MEA or Middle East & Africa and Europe. Americas stands as the biggest market for erectile dysfunction drugs, headed by the United States. The expanding elderly population struggling with the condition has been favorable for the American market, since ED is quite common among men aged above 40. Availability of a wide array of erectile dysfunction drugs via online channels and over the counter (OTC) should further foster the market expansion rate. The prevalence of online pharmacy stores has grown immensely in the region, given that most of the patients are hesitant to visit a retail pharmacy store for purchasing the drugs. The Asia Pacific market can progress at the fastest rate in the coming years, in view of the burgeoning geriatric population prone to ED and the increasing availability of a variety of generic drugs. Government-led reforms as well as public awareness programs in a number of emerging countries like India and China can push the growth trajectory of the regional market. Economic growth, development of the healthcare infrastructure, and rapid expansion of the target population are a few other significant growth boosters in the APAC market. Novel molecule combinations paired with drug delivery methods like using pellets and creams with higher efficacy as well as performance should be a lucrative opportunity for erectile dysfunction drugs manufacturers in the region. Thriving generic drugs sector along with the social stigma attached to the condition will encourage market growth in subsequent years. www.marketresearchfuture.com

  5. Erectile Dysfunction Drugs Market Global Research Report - Forecast till 2025 Application & Major Players in this Research: Some of key the players in the market are • Pfizer Inc. (U.S) • Apricus Biosciences Inc. (U.S). • Bayer AG (Germany) • Dong–A Pharmaceutical Co. Ltd. (South Korea) • S.K. Chemicals Co. Ltd. (South Korea) • Eli Lily & Co. (U.S) • Apricus Biosciences Inc. (U.S) • CristaliaProdutosQuimicosFarmaceuticos Ltd. • Meda Pharmaceuticals, Inc. • S.K. Chemicals Co. Ltd. • Vivus Inc. • Teva Pharmaceutical Industries Ltd. Connect with Our Research Expert: https://www.marketresearchfuture.com/enquiry/1313 www.marketresearchfuture.com

  6. Erectile Dysfunction Drugs Market Global Research Report - Forecast till 2025 About Us: Market Research Future At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. For more information kindly visit www.marketresearchfuture.com or contact us at info@marketresearchfuture.com Copyright © 2018 Market Research Future All Rights Reserved. This document contains highly confidential information and is the sole property of Market Research Future. No part of it may be circulated, copied, quoted, or otherwise reproduced without the written approval of Market Research Future. www.marketresearchfuture.com

  7. MARKET RESEARCH FUTURE THANK YOU salesteam@marketresearchfuture.com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK) www.marketresearchfuture.com

More Related